Response to Tinospora cordifolia (giloy)‐induced liver injury during the COVID‐19 pandemic—Multicenter nationwide study from India
Main Author: | Harshad Devarbhavi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-10-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1989 |
Similar Items
-
Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India
by: Anand V. Kulkarni, et al.
Published: (2022-06-01) -
Response to Tinospora cordifolia (Giloy)‐induced liver injury during the COVID‐19 pandemic—Multicenter nationwide study from India
by: Geethalayam G. Gangadharan, et al.
Published: (2022-10-01) -
Genome sequencing and functional analysis of a multipurpose medicinal herb Tinospora cordifolia (Giloy)
by: Shruti Mahajan, et al.
Published: (2024-02-01) -
Studies on antibacterial activity of extracts from Tinospora cordifolia (Giloy) against Staphylococcus aureus
by: Deepika, et al.
Published: (2009-06-01) -
Tinospora cordifolia (Giloy): An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb
by: Abhishek Gupta, et al.
Published: (2024-02-01)